Home/Filings/4/0001209191-23-057714
4//SEC Filing

Person Julie 4

Accession 0001209191-23-057714

CIK 0001923840other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:04 PM ET

Size

9.3 KB

Accession

0001209191-23-057714

Insider Transaction Report

Form 4
Period: 2023-12-05
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Transactions
  • Sale

    Common Stock

    2023-12-05$10.30/sh12,863$132,4840 total
  • Exercise/Conversion

    Employee Option Grant (right to buy)

    2023-12-05+12,86367,137 total
    Exercise: $4.20Exp: 2032-10-24Common Stock (12,863 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-05$4.20/sh+12,863$54,02512,863 total
Footnotes (3)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0001946505

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:04 PM ET
Size
9.3 KB